These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5240367)

  • 1. Effects of parenteral administration of haloperidol in man. II. Male chronic schizophrenics: quantitative EEG findings.
    Pfeiffer CC; Goldstein L; Sugerman AA
    J Clin Pharmacol J New Drugs; 1968; 8(2):89-94. PubMed ID: 5240367
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of parenteral administration of haloperidol and chlorpromazine in man. I. Normal subjects: quantitative EEG and subjective response.
    Pfeiffer CC; Goldstein L; Murphree HB
    J Clin Pharmacol J New Drugs; 1968; 8(2):79-88. PubMed ID: 5240366
    [No Abstract]   [Full Text] [Related]  

  • 3. Somatosensory-evoked potential changes during haloperidol treatment of chronic schizophrenics.
    Saletu B; Saletu M; Itil T; Marasa J
    Biol Psychiatry; 1971; 3(4):299-307. PubMed ID: 5163816
    [No Abstract]   [Full Text] [Related]  

  • 4. [Predicting the effects of haloperidol on schizophrenics by quantitative pharmaco-EEG].
    Zhang XL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):300-2, 318. PubMed ID: 1291253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
    Wright P; Birkett M; David SR; Meehan K; Ferchland I; Alaka KJ; Saunders JC; Krueger J; Bradley P; San L; Bernardo M; Reinstein M; Breier A
    Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An experimental psychological study on the effect of haloperidol it low dosage administered alone or in combination with alcohol].
    Wambsganss E; Bredenkamp J
    Arzneimittelforschung; 1968 Feb; 18(2):238-43. PubMed ID: 4876969
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrated EEG. variability: drug effects in acute schizophrenics.
    Marjerrison G; Keogh RP
    Can Psychiatr Assoc J; 1969 Aug; 14(4):403-5. PubMed ID: 4897659
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with haldol (haloperidol) in chronic schizophrenics.
    Yun BS; Banner L; Overbey CB
    Mich Med; 1968 Nov; 67(21):1349-51. PubMed ID: 5699514
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients.
    Tuason VB
    J Clin Psychiatry; 1986 Mar; 47(3):126-9. PubMed ID: 3512535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
    Breier A; Meehan K; Birkett M; David S; Ferchland I; Sutton V; Taylor CC; Palmer R; Dossenbach M; Kiesler G; Brook S; Wright P
    Arch Gen Psychiatry; 2002 May; 59(5):441-8. PubMed ID: 11982448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching haloperidol from oral to im depot formulation.
    Perry PJ; Alexander B
    DICP; 1991 Nov; 25(11):1270-1. PubMed ID: 1763548
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia.
    Fang M; Chen H; Li LH; Wu R; Li Y; Liu L; Ye M; Huang J; Zhu S; Wang G; Zhang Q; Zheng H; Zhang L; Wang B; Zhou J; Zhao JP
    Int Clin Psychopharmacol; 2012 Mar; 27(2):107-13. PubMed ID: 22233697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular long-acting fluphenazine in the treatment of schizophrenia.
    Malm U
    Acta Psychiatr Scand; 1970; 46(3):225-37. PubMed ID: 5490589
    [No Abstract]   [Full Text] [Related]  

  • 14. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia.
    Serafetinides EA; Willis D; Clark ML
    J Nerv Ment Dis; 1972 Nov; 155(5):366-9. PubMed ID: 4563078
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative trial of haloperidol and thioridazine: management of chronic schizophrenia.
    Weston MJ; Bentley R; Unwin A; Morris M; Harper MA
    Aust N Z J Psychiatry; 1973 Mar; 7(1):52-7. PubMed ID: 4579393
    [No Abstract]   [Full Text] [Related]  

  • 17. Digital computer analyzed sleep and resting EEG during haloperidol treatment.
    Itil TM; Gannon P; Hsu W; Klingenberg H
    Am J Psychiatry; 1970 Oct; 127(4):462-71. PubMed ID: 4318894
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical investigations and computer analysis of EEG effects of thioridazine hydrochloride on chronic schizophrenics.
    Akpinar S; Itil T; Marasa J; Keskiner A
    Psychiatr Clin (Basel); 1972; 5(5):289-99. PubMed ID: 4559602
    [No Abstract]   [Full Text] [Related]  

  • 19. A clinical trial comparing intramuscular haloperidol decanoate and oral haloperidol in chronic schizophrenic patients: efficacy, safety, and dosage equivalence.
    Vasavan Nair NP; Suranyi-Cadotte B; Schwartz G; Thavundayil JX; Achim A; Lizondo E; Nayak R
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):30S-37S. PubMed ID: 3514689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of intramuscular versus oral haloperidol in schizophrenic patients.
    Schaffer CB; Shahid A; Javaid JI; Dysken MW; Davis JM
    J Clin Psychopharmacol; 1982 Aug; 2(4):274-7. PubMed ID: 7119135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.